Anixa Biosciences, Inc.
Symbol: ANIX (NASDAQ)
3.30
▼ (-2.08%) -0.070
Company Description:
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Key Stats
- Today's Open: $3.38
- Today's High: $3.393
- Today's Low: $3.215
- Today's Volume: 85.60K
- Yesterday Close: $3.37
- Yesterday High: $3.41
- Yesterday Low: $3.3505
- Yesterday Volume: 108.33K
- Last Min Volume: 39
- Last Min High: $3.3
- Last Min Low: $3.3
- Last Min VWAP: $3.3
Company Profile
- Name: Anixa Biosciences, Inc.
- Website: https://www.anixa.com
- Listed Date: 1983-10-07
- Location: SAN JOSE, CA
- Market Status: Active
- CIK Number: 0000715446
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $103.72M
- Round Lot: 100
- Outstanding Shares: 32.21M
- Asset Type: CS
RECENT FILINGS FOR ANIX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-21 | 4 | View |
| 2025-07-15 | 4 | View |
| 2025-07-14 | 4 | View |
| 2025-06-06 | SCHEDULE 13D/A | View |
| 2025-06-05 | 4 | View |
| 2025-05-28 | 10-Q | View |
| 2025-03-21 | 8-K | View |
| 2025-03-11 | 10-Q | View |
| 2025-02-06 | DEF 14A | View |
| 2025-01-29 | 4 | View |
| 2025-01-27 | 4 | View |
| 2025-01-23 | 4 | View |
| 2025-01-22 | 4 | View |
| 2025-01-17 | 4 | View |
| 2025-01-15 | 4 | View |
| 2025-01-15 | 4 | View |
| 2025-01-10 | S-8 | View |
| 2025-01-10 | 10-K | View |
| 2025-01-03 | SCHEDULE 13D/A | View |
| 2025-01-03 | 4 | View |
Latest News on ANIX